Boston University

Arkray of Kyoto, Japan, has been awarded US Patent No. 8,306,754, "Nucleic acid amplification determining method and nucleic acid amplification determining device."
Kosuke Kubo is named as the inventor.

The headline for this story has been updated from a previous version to clarify that the company has completed enrollment for the trial.

This article has been updated from a previous version to clarify that Wave 80 is evaluating the SPE technology but has not licensed it.
By Ben Butkus

Allegro CEO Mike Webb said the licensing agreement will support the "continued advancement" of the firm's BronchoGen test, including a planned commercial launch in the first half of 2012.

The IP licensed by Allegro relates to a gene expression-based platform that detects common molecular responses that occur throughout the respiratory tract in current and former smokers with lung cancer.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.